Despite hopes from N.Y. Gov. Andrew Cuomo (D) and New Jersey Gov. Phil Murphy, REC legalization looks unlikely in either state this year, the N.Y. Times reports.
WeedWeek has relaunched our Patreon Program with swag, gifts and promotional opportunities for supporters. A $25 monthly contribution will score you an Otto automatic grinder and cone filler, (see below ad.) For $100 monthly you’ll see your name and links in this box every week.
Thank you to our Patreon supporters!
CEO, Critical Mind Inc., Adelanto California
Affiliations: CA State Bar; Board member, Adelanto Growers Association
Critical Mind, Inc. is a Medical Cannabis Cultivation and Manufacturing Facility located in Adelanto, CA. Providing the highest quality Cannabis products. Compliance without Compromise!
WeedWeek is launching a new reported business column.
Got tips for future columns? Email me securely: email@example.com
Separately, Green Market Report's Debra Borchardt writes Acreage is selling its real estate assets to a Real Estate Investment Trust (REIT) called GreenAcreage Real Estate Corp. (GARE) which will lease the assets back to Acreage. Acreage CEO Kevin Murphy has invested in GARE.
Harvest Public Media asks whether states can ensure cannabis product safety without help from the feds.
In Sacramento, a bill to cut pot taxes as a way to help licensed businesses, failed to advance, likely dooming it for the year.
Nonetheless, the state industry keeps attracting investment:
KPBS takes a closer look at the San Diego market.
Using Nevada's new transparency law, Cannabis Wire learns who are the major players in Nevada.
Massachusetts regulators gave a "preliminary OK" to a social consumption pilot program, though any businesses offering it could be a long way off.
Las Vegas looks likely to be among the first significant social use markets, and businesses want to make Sin City into the "New Amsterdam."
A bill to allow consumption lounges in Oregon is "100% dead."
Brendan Kennedy, CEO of Canadian MED company Tilray, and Seattle-based investment vehicle Privateer Holdings was the second highest paid CEO of companies traded on U.S. exchanges in 2018. He made just over $256M.
The New York Times Magazine has a fascinating piece by Moises Velasquez-Manoff on the history, hype and promise of CBD as a medicine:
"Why plants produce molecules that seem perfectly designed to manipulate human biochemical circuitry is a mystery. It could be a kind of molecular coincidence. But many plants, including cannabis, might make these molecules to defend themselves from other organisms."
Taking CBD could cause you to fail a drug test, Consumer Reports says.
The N.Y. Times' women's health columnist says it's unknown whether CBD can help with the pelvic pain disorder vaginismus.
While it remains unclear if they have a chance to pass, cannabis reform bills keep piling up in Washington D.C.:
Joe Biden, frontrunner for the Democrats' 2020 nomination, endorsed cannabis decriminalization, but not legalization.
Cannabis Now looks into the case of Alkiviades "Alki" David, who was arrested on the island of St. Kitts after authorities found about 5,000 plants and cuttings on his private jet. David is the founder of SwissX hemp products and an heir to a European Coke bottling fortune.
The nation of Saint Kitts and Nevis appears to be in the process of reforming its cannabis laws. David, who claims the cargo is all hemp, says he and a business partner were arrested after talks with the prime minister about creating a local hemp industry broke down.
Following the vote in Denver to decriminalize psychedelic mushrooms, there's a lot of talk about what comes next.
Wired reports on the first placebo-controlled studies into microdosing LSD.
Since 2015, WeedWeek has been the best way to keep up with the Green Rush. Subscribe to our free newsletters today!